Hemasphere

Activating mutations remodel the chromatin accessibility landscape to drive distinct regulatory networks in KMT2A-rearranged acute leukemia.

Zhang Q, Falqués-Costa T, Pilheden M, ..., Hyrenius-Wittsten A, Hagström-Andersson AK

Hemasphere 8 (9) e70006 [2024-09-00; online 2024-09-26]

Clinical Genomics [Service] Clinical Genomics Lund [Service]

Duplex Sequencing Uncovers Recurrent Low-frequency Cancer-associated Mutations in Infant and Childhood KMT2A-rearranged Acute Leukemia.

Pilheden M, Ahlgren L, Hyrenius-Wittsten A, ..., Gawad C, Hagström-Andersson AK

Hemasphere 6 (10) e785 [2022-10-00; online 2022-09-30]

Clinical Genomics [Service] Clinical Genomics Lund [Service]

Five Percent Variant Allele Frequency Is a Reliable Reporting Threshold for TP53 Variants Detected by Next Generation Sequencing in Chronic Lymphocytic Leukemia in the Clinical Setting.

Pandzic T, Ladenvall C, Engvall M, ..., Ljungström V, Baliakas P

Hemasphere 6 (8) e761 [2022-08-00; online 2022-08-02]

Bioinformatics Support for Computational Resources [Service] Clinical Genomics [Collaborative] Clinical Genomics Uppsala [Collaborative]

Ibrutinib Has Time-dependent On- and Off-target Effects on Plasma Biomarkers and Immune Cells in Chronic Lymphocytic Leukemia.

Mulder TA, Peña-Pérez L, Berglöf A, ..., Smith CIE, Palma M

Hemasphere 5 (5) e564 [2021-05-00; online 2021-04-26]

Bioinformatics Support for Computational Resources [Service]